1. Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion 
Laurent Garderet, Dimitris Ziagkos, Anja van Biezen, Simona Iacobelli, Jürgen Finke, Johan Maertens, Liisa Volin, Per Ljungman, Patrice Chevallier, Jakob Passweg, Nicolaas Schaap, Dietrich Beelen, Arnon Nagler, Didier Blaise, Xavier Poiré, Ibrahim Yakoub-Agha, Stig Lenhoff, Charles Craddock, Rik Schots, Alessandro Rambaldi, Jaime Sanz, Pavel Jindra, Ghulam J. Mufti, Marie Robin, Nicolaus Kröger 
Biology of Blood and Marrow Transplantation 
Volume 24, Issue 3, Pages (March 2018)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
OS after allogeneic stem cell transplantation in patients with a del (5q) karyotype.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
OS survival after allogeneic stem cell transplantation in patients with a del (5q) karyotype, with or without an excess of blasts.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
RI and NRM after allogeneic stem cell transplantation in patients with a del (5q) karyotype, with or without an excess of blasts.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions